Rapid Evaluation of Pandemic H1N1 Influenza Vaccine in Adults With HIV

NCT01002040 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

150

Enrollment

OTHER

Sponsor class

Conditions

HIV Infections
H1N1 Influenza

Interventions

BIOLOGICAL: Arepanrix
BIOLOGICAL: Arepanrix

Sponsor

University of British Columbia

Collaborators

[object Object]
[object Object]